The ratio of CD56 strongly positive cells to CD56 weakly positive cells positively correlated with IgG levels and was directly proportional to disease activity, indicating that this ratio could be used as a specific indicator of SS. This evidence concerns the gene NCAM1 and synovial sarcoma.